Literature DB >> 28579039

Total mismatch of diffusion-weighted imaging and susceptibility-weighted imaging in patients with acute cerebral ischemia.

Min-Gyu Park1, Jeong A Yeom2, Seung Kug Baik2, Kyung-Pil Park3.   

Abstract

BACKGROUND AND
PURPOSE: Multiple hypointense vessels (MHV) on susceptibility-weighted imaging (SWI) is associated with an increased oxygen demand in acute cerebral ischemia. Occasionally, some patients exhibit extensive MHV on SWI despite of negative diffusion-weighted imaging (DWI), which is a phenomenon called total mismatch DWI-SWI. We analyzed the clinical characteristics and imaging findings in patients with the total DWI-SWI mismatch.
MATERIALS AND METHODS: We selected patients with total DWI-SWI mismatch who underwent MRI within 12hours from onset. To evaluate the degree of collateral flow, we graded vessels on post-contrast time-of-flight MR angiography as 3 groups. Perfusion lesion volume was measured using threshold of>6seconds of mean transit time on perfusion-weighted imaging.
RESULTS: Total DWI-SWI mismatch was found in 10 (2.7%) out of 370 patients. Four out of 10 patients were excluded due to lack of data on perfusion studies. Hence 6 patients were finally selected in the study. Two patients with internal carotid artery dissection were treated with emergent stenting, one patient with intravenous thrombolysis and mechanical thrombectomy, and two patients with drug-induced hypertension. All of the enrolled patients exhibited extensive MHV on SWI and good collateral flows. The mean perfusion lesion volume was 72.6±15.3ml (range 0-325.0ml). Clinical outcome was favorable in all of the patients (mRS at 3 months, 0).
CONCLUSIONS: Our results demonstrate that total mismatch of DWI-SWI is associated with good collateral flow and may be a predictor of good response to treatment in patients with acute cerebral ischemia.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute stroke; Collaterals; Diffusion-weighted imaging; Magnetic resonance imaging; Penumbra; Perfusion MRI

Mesh:

Substances:

Year:  2017        PMID: 28579039     DOI: 10.1016/j.neurad.2017.04.002

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  6 in total

1.  Are prominent medullary veins better than prominent cortical veins as predictors of early clinical outcome in patients with acute ischemic stroke?

Authors:  Lina Jing; Binbin Sui; Mi Shen; Haiqiang Qin; Peiyi Gao
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

Review 2.  Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy.

Authors:  Lucie Chalet; Timothé Boutelier; Thomas Christen; Dorian Raguenes; Justine Debatisse; Omer Faruk Eker; Guillaume Becker; Norbert Nighoghossian; Tae-Hee Cho; Emmanuelle Canet-Soulas; Laura Mechtouff
Journal:  Front Cardiovasc Med       Date:  2022-03-09

3.  Susceptibility-diffusion mismatch correlated with leptomeningeal collateralization in large vessel occlusion stroke.

Authors:  Haifei Jiang; Yiqun Zhang; Jiangxia Pang; Chaojie Shi; Ao-Fei Liu; Chen Li; Min Jin; Fengyuan Man; Wei-Jian Jiang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  The Influence of Cerebral Arterial Circle on Prominent Hypointense Vessel Signs in Patients With Internal Carotid Artery Occlusion.

Authors:  Lei Yang; Ling Yu; Wei Qin; Yue Li; Shuna Yang; Xuanting Li; Wenli Hu
Journal:  Front Neurol       Date:  2022-01-14       Impact factor: 4.003

5.  The role of asymmetrical prominent veins sign in early neurological deterioration of acute ischemic stroke patients.

Authors:  Kuankuan Huang; Jianfang Liu; Wenwei Yun; Yin Cao; Min Zhang
Journal:  Front Neurol       Date:  2022-08-15       Impact factor: 4.086

6.  Asymmetric Deep Medullary Veins in Patients With Occlusion of a Large Cerebral Artery: Association With Cortical Veins, Leptomeningeal Collaterals, and Prognosis.

Authors:  Zhihua Xu; Yang Duan; Benqiang Yang; Xin Huang; Yusong Pei; Xiaoqiu Li
Journal:  Front Neurol       Date:  2019-12-05       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.